Does RISANKIZUMAB-RZAA Cause Skin discolouration? 315 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 315 reports of Skin discolouration have been filed in association with RISANKIZUMAB-RZAA. This represents 0.5% of all adverse event reports for RISANKIZUMAB-RZAA.
315
Reports of Skin discolouration with RISANKIZUMAB-RZAA
0.5%
of all RISANKIZUMAB-RZAA reports
2
Deaths
62
Hospitalizations
How Dangerous Is Skin discolouration From RISANKIZUMAB-RZAA?
Of the 315 reports, 2 (0.6%) resulted in death, 62 (19.7%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Skin discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 315 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Skin discolouration?
ADAPALENE (2,541)
DUPILUMAB (2,121)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (2,102)
ADALIMUMAB (1,598)
LENALIDOMIDE (1,566)
ETANERCEPT (1,051)
CAPECITABINE (836)
SECUKINUMAB (828)
METHOTREXATE (545)
APIXABAN (391)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Skin discolouration Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA